SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA inspects Neuland Laboratories’ Unit 2 manufacturing facility in Telangana

03 May 2025 Evaluate

The United States Food and Drug Administration (USFDA) has inspected Neuland Laboratories’ Unit 2 manufacturing facility, located at Pashamylaram village, Sangareddy District, in Telangana from April 28, 2025 to May 2, 2025.

The FDA issued Form 483, with one observation related to building and facility management, which the company will respond to within the stipulated timelines.

Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry’s chemistry needs.


Neuland Laboratories Share Price

14775.05 -156.40 (-1.05%)
22-Apr-2026 10:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.25
Dr. Reddys Lab 1214.95
Cipla 1227.85
Zydus Lifesciences 928.65
Lupin 2297.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×